Aktie A1C9F1 KINGWORLD MEDICINES GROUP LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kingworld Medicines Group Limited

Aktien

A1C9F1

KYG5268M1006

1110

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:42 28.06.2024 		% 5 Tage % 1. Jan.
0.6 HKD +7.14% Intraday Chart für Kingworld Medicines Group Limited +5.26% -4.76%
29.05. Kingworld Medicines Group Limited genehmigt Schlussdividende fur das Jahr bis zum 31. Dezember 2023 CI
23.04. Kingworld Medicines verzeichnet 68% Gewinnsprung im Jahr 2023 MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2023
Kingworld Medicines Posts 68% Jump in 2023 Profit
Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Kingworld Medicine Expects Up to 75% Profit Jump in 2023; Shares Up 6%
Kingworld Medicines Group Limited Provides consolidated Earnings Guidance for the Year Ended 31 December 2023
Net Profit of Kingworld Medicines Increased By 55.8%
Net Profit of Kingworld Increased By 35.9% YoY
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical
Kingworld Further Subscribed For 2.08% Equity of Taiko Pharmaceutical To Optimize Its Layout of Pharmaceutical Industry
Kingworld Medicines Group Expects Up to 40% Rise in H1 Profit
Kingworld Medicines Expects 1H Profit Increased By 35%-40%
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023
Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical
Kingworld Medicines to Grant 3.5 Million Awarded Shares Under 2019 Scheme
Kingworld Medicines Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Kingworld Medicines Earns "Shenzhen Time-honored Brand" Title Again
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1C9F1 Aktie
  4. Nachrichten Kingworld Medicines Group Limited
  5. Andere Sprachen